Admedus acquires manufacturing facility from Genzyme Australasia
13 December, 2013Healthcare group Admedus (formerly Allied Healthcare) has signed a share purchase agreement to acquire an established manufacturing site from Genzyme Australasia, a Sanofi company. Admedus purchased the site to facilitate scaled-up production of its regenerative tissue product CardioCel.
Merck Biopharm osteoarthritis co-research agreement
22 November, 2013Biopharm and Merck Serono have entered a joint discovery project focusing on a potential pro-anabolic osteoarthritis modifying drug based on a growth factor derived from the Biopharm growth factor platform technology.
LabGear appointed as distributor for Grant and Planer
29 October, 2013LabGear Australia has been appointed as a distributor for Grant Instruments and the exclusive distributor in Australia and New Zealand for Planer. Both companies are based in the UK.
Sartorius to acquire TAP Biosystems
08 October, 2013Laboratory and pharmaceutical equipment provider Sartorius Stedim Biotech has made a cash offer to acquire UK company TAP Biosystems through its wholly owned subsidiary, Sartorius Stedim Biotech GmbH.
Seal Analytical acquires Thomas Cain
02 October, 2013Seal Analytical - a global supplier of automated colorimetric analyser instrumentation - has acquired Thomas Cain. Seal Analytical says the acquisition will enhance its capabilities in the water and soil analysis markets.
AXT to distribute TTP Labtech life science products in A/NZ
13 September, 2013Analytical and sample preparation equipment supplier ATX has become the exclusive Australian and New Zealand agent for UK-based TTP Labtech's life science product range. TTP Labtech is a developer and manufacturer of products for pharmaceutical and biotech research at both the industrial and academic levels.
Rigaku and Emerald Bio announce strategic alliance in protein crystallography
02 August, 2013Rigaku, a supplier of X-ray instrumentation and automation equipment for structural biology, has acquired the crystallisation reagent and consumable business, including Wizard screens, from protein science company Emerald Bio.
Trajan completes SGE acquisition
12 July, 2013Trajan Scientific and Medical has completed its acquisition of the chromatography and liquid handling businesses of SGE Analytical Science.
United Bioresearch appointed Australian distributor for Abiocode
03 May, 2013United Bioresearch has announced its appointment as the Australian distributor for Californian-based Abiocode.
Qiagen acquires Ingenuity Systems
01 May, 2013Qiagen has announced the acquisition of Ingenuity Systems, a provider of software solutions that efficiently and accurately analyse and interpret the biological meaning of genomic data.
Scitek now representing LC Technology Solutions
30 April, 2013LC Technology Solutions has teamed up with Scitek Australia as its exclusive distributor in Australia and New Zealand.
Thermo Fisher Scientific to acquire Life Technologies Corporation
16 April, 2013Thermo Fisher Scientific and Life Technologies Corporation have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as of year-end 2012).
Applikon Biotechnology acquires biotech portfolio from HaloteC Instruments
04 April, 2013Bioreactor systems company Applikon Biotechnology has signed a definitive agreement to acquire the biotechnology portfolio of HaloteC Instruments, a Dutch provider of instruments and software solutions for the biotech market.
Lonza and Hyglos reach agreement for Endotoxin detection patents
15 March, 2013Lonza Walkersville and Hyglos GmbH have reached a mutually beneficial global settlement which includes a licence agreement for Hyglos under certain Lonza patents in the area of endotoxin detection.
BioReliance acquires rights to Big Blue colonies and cell lines from Agilent
06 March, 2013Sigma-Aldrich Corporation has announced that BioReliance has signed an agreement to acquire the colonies required for the Big Blue transgenic rodent mutation (TRM) assay and to obtain a licence to its associated trademark from Agilent Technologies.
